Pharmaceuticals

Global Antipsychotic Drugs Market Forecast 2026–2035: Long-Term Growth Insights

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antipsychotic drugs market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Antipsychotic Drugs Market?

The antipsychotic drugs market size has experienced robust growth in recent years. This market is projected to expand from $21.25 billion in 2025 to $23.23 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. Key factors contributing to this historical expansion include the emergence of first-generation antipsychotics, increased understanding of mental health conditions, the development of hospital and clinical facilities, an uptick in the incidence of schizophrenia and bipolar disorder, and enhanced research and development spending on neuropsychiatric medications.

The market for antipsychotic drugs is projected to experience robust expansion in the coming years. This market is set to reach a value of $33.26 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. The anticipated growth during this period is fueled by several factors, including progress in atypical and partial dopamine agonists, the embrace of precision medicine strategies, the incorporation of AI into mental health diagnostics, the widening reach of online pharmacy distribution, and a heightened emphasis on long-acting injectable formulations. Key trends anticipated during the forecast encompass personalized antipsychotic treatment, the growing elderly demographic, a higher incidence of schizophrenia and bipolar disorder, the rise of telepsychiatry and digital mental health platforms, and the ongoing development of long-acting injectable antipsychotics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp

Which Drivers Are Supporting The Rise Of The Antipsychotic Drugs Market?

The increasing prevalence of mental disorders is anticipated to fuel the expansion of the antipsychotic drug market in the future. Mental disorders, also known as mental illnesses, are conditions that affect an individual’s thoughts, actions, mood, and overall mental health. Instances of mental disorders can be influenced by stress levels, societal pressures, genetic predisposition, biochemical imbalances, neurodevelopmental issues, and various physical health conditions. Antipsychotic drugs work to manage mental disorders by modifying the activity of neurotransmitters, mainly dopamine and serotonin, to alleviate psychotic symptoms, stabilize mood, and enhance both cognitive and emotional function. For example, a survey conducted in November 2023 by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based government public health agency, found that approximately 6% of adults aged 18 or older, totaling 15.4 million individuals, reported experiencing serious mental illness (SMI). Furthermore, in September 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, projected that the number of people living with dementia in Australia is expected to more than double from around 411,100 in 2023 to 849,300 by 2058. This surge will affect approximately 315,500 men and 533,800 women. Hence, the rising incidence of mental disorders is a key driver for the antipsychotic drug market.

What Leading Segments Are Studied In The Antipsychotic Drugs Market?

The antipsychotic drugs market covered in this report is segmented –

1) By Therapeutic Class: First Generation, Second Generation, Third Generation

2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines

2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone

3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

Which Innovation Trends Are Advancing Developments Within The Antipsychotic Drugs Market?

Major companies operating in the antipsychotic drug market are focusing on creating advanced medical products, including subcutaneous atypical antipsychotic injections, to offer better patient compliance and enhanced effectiveness compared to traditional oral medications. These subcutaneous atypical antipsychotic injections are psychiatric drugs given under the skin to treat mental illnesses, sustain stable blood levels, and improve symptom management. For example, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a France-based manufacturer of biological products and pharmaceutical preparations, launched U.S. Food and Drug Administration (FDA)-approved UZEDY. This product is an extended-release injectable formulation of risperidone, developed as a long-acting subcutaneous injection that allows flexible dosing intervals of one or two months. UZEDY utilizes MedinCell’s proprietary SteadyTeq technology, which guarantees a consistent release of the medication, reaching therapeutic levels within 6–24 hours of administration. In clinical trials, UZEDY demonstrated up to an 80% reduction in the risk of schizophrenia relapse compared to placebo. Its purpose is to address adherence problems commonly linked with oral antipsychotics, which often lead to a recurrence of symptoms.

Which Major Industry Participants Are Leading The Antipsychotic Drugs Market Growth?

Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Antipsychotic Drugs Market?

North America was the largest region in the antipsychotic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antipsychotic Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp

Browse Through More Reports Similar to the Global Antipsychotic Drugs Market 2026, By The Business Research Company

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Epilepsy Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/epilepsy-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795